TDPel Media News Agency

CMA helps NHS secure price and supply commitment for cancer drugs

tdpel
By tdpel
Published: April 28, 2022 | 12:11 PM GMT

The European Commission opened an investigation into Aspen in 2017 to investigate concerns that the company had engaged in excessive pricing for 6 off-patent cancer medicines. Last year the European Commission accepted commitments by Aspen to reduce prices for the 6 medicines to address these concerns.

As a result, Aspen reduced its prices across Europe – including in the UK – by an average of approximately 73%. In addition, Aspen guaranteed the supply of the 6 cancer medicines for a period of 5 years, and, for an additional 5-year period, will either continue to supply or make its marketing authorisation available to other suppliers. This means that over the 10-year period, Aspen cannot charge more than the price set out in the commitments.

Although these commitments were offered while the UK was a part of the European Union, the commitments became legally binding under EU law after the UK was no longer part of the EU.

The CMA has now assisted the NHS to secure binding undertakings from Aspen, under the law of England and Wales, which enshrine the UK elements of the commitments and are enforceable by UK courts, including in relation to the supply of these drugs in Northern Ireland and Scotland. This means that the NHS will have effective mechanisms to monitor and ensure compliance by Aspen following the UK’s exit from the EU.

CMA helps NHS secure price and supply commitment for cancer drugs Thank You

Related posts:

  1. CMA accuses pharmaceutical companies of overcharge the NHS for vital anti-epilepsy drugs After reexamining the case, the CMA provisionally concluded that Pfizer…
  2. Saveetha Oral Cancer Institute Conducts a Free Cancer Screening and Awareness Program in Commemoration of World Cancer Day Saveetha Oral Cancer Institute conducts a free cancer screening and…
  3. CMA fines firms over £35m for illegal arrangement for NHS drug The CMA has fined firms over £35 million for an…
  4. Six new NHS trusts to receive funding for trial of Cancer treatment with AI Six new NHS trusts across England will receive funding for…
  5. Government aims to eradicate modern slavery from NHS supply chains Landmark Health and Care Bill amendment will crack down on…
  6. Technology Innovation Institute’s Secure Systems Research Centre Collaborates with Global Universities on Secure Mesh Communications Research Projects Technology Innovation Institute’s Secure Systems Research Centre Collaborates with Global…
  7. TII’s Secure Systems Research Centre announces integration of secure PX4 stack into RISC-V based drone TII’s Secure Systems Research Centre announces integration of secure PX4…
  8. Lebanese tattoo artist helps breast cancer survivors to heal For Lebanese breast cancer survivor Roula Saad, a decade-long struggle…
  9. International Atomic Energy Agency (IAEA) Helps Combat Skin Cancer in Namibia Cancer cases are on the rise in Namibia, including skin cancer…
  10. NHIS to subsidize Cancer drugs by 80% Enrollees under the National Health Insurance Scheme in Nigeria,NHIS, will…

Breaking News

»TDPel Media News« »For Breaking News«| »For Featured«| »For Biographies« »For Lifestyle« »For Lottery« »For Fashion« »For Politics« »For Business« »For Entertainment« »For Wellness and Fitness« »For Religion« »For Science« »For Sports« »For Technology« »For Health« »For TDPelTV« »For World News« »TDPel Media News« »For TDPel Community« »TDPel Media News« »For Breaking News«| »For Featured«| »For Biographies« »For Lifestyle« »For Lottery« »For Fashion« »For Politics« »For Business« »For Entertainment« »For Wellness and Fitness« »For Religion« »For Science« »For Sports« »For Technology« »For Health« »For TDPelTV« »For World News« »TDPel Media News« »For TDPel Community«
Spread the News. Auto-share on
Facebook Twitter Reddit LinkedIn
tdpel profile photo on TDPel Media

About tdpel

Pelumi Emmanuel is an accomplished writer and journalist with over 15 years of experience in the industry. He is a passionate and dedicated professional who is committed to producing high-quality content that informs, engages, and entertains readers. Pelumi’s love for reading and writing is evident in his work, which has been read worldwide and has garnered him a loyal following. His journalistic expertise is matched only by his natural talent for storytelling, making his articles both informative and engaging. He lives in California, USA.